Zaloguj się

Gotowe bibliografie tematyczne / Interleukin-6 / Artykuły w czasopismach

Kliknij ten link, aby zobaczyć inne rodzaje publikacji na ten temat: Interleukin-6.

Artykuły w czasopismach na temat „Interleukin-6”

Autor: Grafiati

Data publikacji: 4 czerwca 2021

Data aktualizacji: 25 lipca 2025

Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych

Wybierz rodzaj źródła:

Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Interleukin-6”.

Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.

Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.

Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.

1

&NA;. "Interleukin-3/interleukin-6." Reactions Weekly &NA;, no. 550 (1995): 11. http://dx.doi.org/10.2165/00128415-199505500-00035.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

2

&NA;. "Interleukin-6." Reactions Weekly &NA;, no. 570 (1995): 9. http://dx.doi.org/10.2165/00128415-199505700-00023.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

3

Lotz, Martin. "Interleukin-6." Cancer Investigation 11, no. 6 (1993): 732–42. http://dx.doi.org/10.3109/07357909309046948.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

4

&NA;. "Interleukin 6." Inpharma Weekly &NA;, no. 877 (1993): 2. http://dx.doi.org/10.2165/00128413-199308770-00001.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

5

&NA;. "Interleukin 6." Reactions Weekly &NA;, no. 505 (1994): 8. http://dx.doi.org/10.2165/00128415-199405050-00037.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

6

&NA;. "Interleukin 6." Reactions Weekly &NA;, no. 531 (1994): 8. http://dx.doi.org/10.2165/00128415-199405310-00027.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

7

Song, Mingchen, and John A. Kellum. "Interleukin-6." Critical Care Medicine 33, Suppl (2005): S463—S465. http://dx.doi.org/10.1097/01.ccm.0000186784.62662.a1.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

8

CASTELL, JOSé V., TILO ANDUS, DIETER KUNZ, and PETER C. HEINRICH. "Interleukin-6." Annals of the New York Academy of Sciences 557, no. 1 (2008): 87–101. http://dx.doi.org/10.1111/j.1749-6632.1989.tb24001.x.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

9

LEE, FRANK, CHOY-PIK CHIU, JANUSZ WIDEMAN, et al. "Interleukin-6." Annals of the New York Academy of Sciences 557, no. 1 (2008): 215–29. http://dx.doi.org/10.1111/j.1749-6632.1989.tb24015.x.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

10

CLARK, STEVEN C. "Interleukin-6." Annals of the New York Academy of Sciences 557, no. 1 (2008): 438–43. http://dx.doi.org/10.1111/j.1749-6632.1989.tb24036.x.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

11

Olencki, Thomas, James Finke, and Ronald M. Bukowski. "Interleukin-6." Clinical Immunotherapeutics 2, no. 4 (1994): 278–94. http://dx.doi.org/10.1007/bf03258528.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

12

Sin, Don D., and S. F. Paul Man. "Interleukin-6." Chest 133, no. 1 (2008): 4–6. http://dx.doi.org/10.1378/chest.07-2085.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

13

Delk, Nikki A., and Mary C. Farach-Carson. "Interleukin-6." Autophagy 8, no. 4 (2012): 650–63. http://dx.doi.org/10.4161/auto.19226.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

14

Matsuda, Tadashi, and Toshio Hirano. "Interleukin 6 (IL-6)." Biotherapy 2, no. 4 (1990): 363–73. http://dx.doi.org/10.1007/bf02170085.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

15

Annisa, Yuanita Anggreini1 GontarAlamsyah Siregar*2 &. Leonardo Basa Dairi3. "ASSOCIATION BETWEEN INTERLEUKIN 6 SERUM LEVEL AND NON-ALCOHOLIC FATTY LIVER DISEASE." INTERNATIONAL JOURNAL OF RESEARCH SCIENCE & MANAGEMENT 6, no. 7 (2019): 11–16. https://doi.org/10.5281/zenodo.3342743.

Pełny tekst źródła

Streszczenie:

<strong>Background. </strong>Non-Alcoholic Fatty Liver Disease (NAFLD) emerged as a major health problem throughout the world and is increasing as the prevalence of obesity and diabetes continues to increase and is recognized as a major cause of liver disease-related morbidity and mortality. Adipokine is critically involved in healthy liver physiology and in the pathophysiology of acute and chronic liver disease as an intermediary for liver inflammation, liver cell death, cholestasis, and fibrosis. Interleukin-6 (IL-6) is one of adipokines widely studied recently. IL-6 showed improvement and p

Style APA, Harvard, Vancouver, ISO itp.

16

Rivera-Chavez, Fernando A., Dixie L. Peters-Hybki, Robert C. Barber, and Grant E. O'Keefe. "Interleukin-6 Promoter Haplotypes and Interleukin-6 Cytokine Responses." Shock 20, no. 3 (2003): 218–23. http://dx.doi.org/10.1097/00024382-200309000-00004.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

17

Ridker, Paul M. "Targeting Interleukin-1 and Interleukin-6." Journal of the American College of Cardiology 76, no. 15 (2020): 1774–76. http://dx.doi.org/10.1016/j.jacc.2020.08.052.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

18

NORTHEMANN, WOLFGANG, TODD A. BFUCIAK, MASAHIRA HATTORI, and GEORG H. FEY. "Rat Interleukin-6." Annals of the New York Academy of Sciences 557, no. 1 (2008): 536–39. http://dx.doi.org/10.1111/j.1749-6632.1989.tb24057.x.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

19

Schneider, Kirsten, Reinhard Klaas, Bernd Kaspers, and Peter Staeheli. "Chicken interleukin-6." European Journal of Biochemistry 268, no. 15 (2001): 4200–4206. http://dx.doi.org/10.1046/j.1432-1327.2001.02334.x.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

20

Tamura, T., N. Udagawa, N. Takahashi, et al. "Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6." Proceedings of the National Academy of Sciences 90, no. 24 (1993): 11924–28. http://dx.doi.org/10.1073/pnas.90.24.11924.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

21

Ogawa, Michio, Kiyoshi Sakamoto, Seiji Mita, Takatoshi Ishiko, and Saburo Hisano. "INTERLEUKIN-6 AND SOLUBLE INTERLEUKIN-6 RECEPTOR IN SURGICAL TRAUMA." Shock 4, Supplement (1995): 11. http://dx.doi.org/10.1097/00024382-199512001-00045.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

22

De Filippo, G., D. Rendina, F. Moccia, V. Rocco, and A. Campanozzi. "Interleukin-6, soluble interleukin-6 receptor/interleukin-6 complex and insulin resistance in obese children and adolescents." Journal of Endocrinological Investigation 38, no. 3 (2014): 339–43. http://dx.doi.org/10.1007/s40618-014-0176-4.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

23

Oka, Masaaki, Hiroshi Kusanagi, Toshihiro Saeki, et al. "Interleukin-6 Production and Interleukin-6 Receptor Expression in Human Esophageal Cancer Cell Lines." Japanese Journal of Gastroenterological Surgery 26, no. 11 (1993): 2707. http://dx.doi.org/10.5833/jjgs.26.2707.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

24

Prens, Errol P., Klazina Benne, Jozef van Damme, et al. "Interleukin-1 and Interleukin-6 in Psoriasis." Journal of Investigative Dermatology 95, no. 6 (1990): S121—S124. http://dx.doi.org/10.1111/1523-1747.ep12874991.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

25

Bota, Rafaqat, and Mushtaq Ahmed. "The pathophysiological profile of interleukin-6 and anti-interleukin-6 antibody." El Mednifico Journal 1, no. 2 (2013): 51. http://dx.doi.org/10.18035/emj.v1i2.26.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

26

Ridker, Paul M., and Manas Rane. "Interleukin-6 Signaling and Anti-Interleukin-6 Therapeutics in Cardiovascular Disease." Circulation Research 128, no. 11 (2021): 1728–46. http://dx.doi.org/10.1161/circresaha.121.319077.

Pełny tekst źródła

Streszczenie:

IL (interleukin)-6 is a pivotal cytokine of innate immunity, which enacts a broad set of physiological functions traditionally associated with host defense, immune cell regulation, proliferation, and differentiation. Following recognition of innate immune pathways leading from the NLRP3 (NOD-, LRR-, and pyrin domain-containing protein 3) inflammasome to IL-1 to IL-6 and on to the hepatically derived clinical biomarker CRP (C-reactive protein), an expanding literature has led to understanding of the proatherogenic role for IL-6 in cardiovascular disease and thus the potential for IL-6 inhibitio

Style APA, Harvard, Vancouver, ISO itp.

27

Jucker, M., H. Abts, W. Li, et al. "Expression of interleukin-6 and interleukin-6 receptor in Hodgkin's disease." Blood 77, no. 11 (1991): 2413–18. http://dx.doi.org/10.1182/blood.v77.11.2413.2413.

Pełny tekst źródła

Streszczenie:

Abstract Interleukin-6 (IL-6) is a multipotent lymphokine that can mediate differentiation of B cells into Ig-secreting cells, stimulate the growth of plasmacytomas, hybridomas, and T cells, and induce acute- phase proteins in liver cells. It has been suggested that IL-6 is involved in the pathogenesis of several diseases by autocrine or paracrine pathways. To examine whether IL-6 is possibly involved in the pathophysiology of Hodgkin's disease (HD), we analyzed the expression of IL-6 and IL-6 receptor mRNA and protein in cell lines and primary specimens from patients with HD. IL-6-specific tr

Style APA, Harvard, Vancouver, ISO itp.

28

Jucker, M., H. Abts, W. Li, et al. "Expression of interleukin-6 and interleukin-6 receptor in Hodgkin's disease." Blood 77, no. 11 (1991): 2413–18. http://dx.doi.org/10.1182/blood.v77.11.2413.bloodjournal77112413.

Pełny tekst źródła

Streszczenie:

Interleukin-6 (IL-6) is a multipotent lymphokine that can mediate differentiation of B cells into Ig-secreting cells, stimulate the growth of plasmacytomas, hybridomas, and T cells, and induce acute- phase proteins in liver cells. It has been suggested that IL-6 is involved in the pathogenesis of several diseases by autocrine or paracrine pathways. To examine whether IL-6 is possibly involved in the pathophysiology of Hodgkin's disease (HD), we analyzed the expression of IL-6 and IL-6 receptor mRNA and protein in cell lines and primary specimens from patients with HD. IL-6-specific transcripts

Style APA, Harvard, Vancouver, ISO itp.

29

Plenz, Gabriele, Heike Eschert, Michael Erren, et al. "The interleukin-6/interleukin-6-receptorsystem is activated in donor hearts." Journal of the American College of Cardiology 39, no. 9 (2002): 1508–12. http://dx.doi.org/10.1016/s0735-1097(02)01791-6.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

30

Nancey, Stéphane, Nadim Hamzaoui, Driffa Moussata, Ivan Graber, Jacques Bienvenu, and Bernard Flourie. "Serum Interleukin-6, Soluble Interleukin-6 Receptor and Crohn’s Disease Activity." Digestive Diseases and Sciences 53, no. 1 (2007): 242–47. http://dx.doi.org/10.1007/s10620-007-9849-6.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

31

Angelis, Pela, Simon Scharf, Alastair Mander, Frank Vajda, and Nicholas Christophidis. "Serum interleukin-6 and interleukin-6 soluble receptor in Alzheimer's disease." Neuroscience Letters 244, no. 2 (1998): 106–8. http://dx.doi.org/10.1016/s0304-3940(98)00136-0.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

32

Rezai, Ali R., Ahmad Rezai, Otoniel Mart�nez-Maza, Meta Vander-Meyden, and Martin H. Weiss. "Interleukin-6 and interleukin-6 receptor gene expression in pituitary tumors." Journal of Neuro-Oncology 19, no. 2 (1994): 131–35. http://dx.doi.org/10.1007/bf01306454.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

33

MONTERO-JULIAN, F. A., E. GAUTHEROT, J. WIJDENES, B. KLEIN, and H. BRAILLY. "Pharmacokinetics of Interleukin-6 During Therapy with Anti-Interleukin-6 Monoclonal Antibodies: Enhanced Clearance of Interleukin-6 by a Combination of Three Anti-Interleukin-6 Antibodies." Journal of Interferon Research 14, no. 5 (1994): 301–2. http://dx.doi.org/10.1089/jir.1994.14.301.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

34

KENIS, G., C. TEUNISSEN, R. DEJONGH, E. BOSMANS, H. STEINBUSCH, and M. MAES. "STABILITY OF INTERLEUKIN 6, SOLUBLE INTERLEUKIN 6 RECEPTOR, INTERLEUKIN 10 AND CC16 IN HUMAN SERUM." Cytokine 19, no. 5 (2002): 228–35. http://dx.doi.org/10.1016/s1043-4666(02)91961-7.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

35

Kenis, Gunter, Charlotte Teunissen, Raf De Jongh, Eugène Bosmans, Harry Steinbusch, and Michael Maes. "STABILITY OF INTERLEUKIN 6, SOLUBLE INTERLEUKIN 6 RECEPTOR, INTERLEUKIN 10 AND CC16 IN HUMAN SERUM." Cytokine 19, no. 5 (2002): 228–35. http://dx.doi.org/10.1006/cyto.2002.1961.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

36

HIRANO, TOSHIO. "Interleukin 6 (IL-6) and disease." Japanese Journal of Clinical Immunology 13, no. 5 (1990): 444–45. http://dx.doi.org/10.2177/jsci.13.444.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

37

Van Wagoner, N. J., and E. N. Benveniste. "Interleukin-6 regulation in human astrocytes: Synergy between TNF-alpha, interleukin-6, and the soluble-interleukin-6 receptor-alpha." Journal of Neuroimmunology 90, no. 1 (1998): 53. http://dx.doi.org/10.1016/s0165-5728(98)91497-7.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

38

Abasova, Dunya, Sevda Kazimova, Nazrin Macidova, Telli Shirinova, and Shalala Babayeva. "STUDY OF STOKIN STATUS IN PATIENTS WITH TOXOPLASMOSIS." Annali d'Italia 50 (December 26, 2023): 17–19. https://doi.org/10.5281/zenodo.10432472.

Pełny tekst źródła

Streszczenie:

The problem of opportunistic infections is becoming an urgent problem of modern times is becoming, which is a constant increase in the number of people infected with HIV, it is related to the increase in aggressive treatment methods of oncopathologies. This infections Pathogens that can normally cause disease in healthy individuals caused by Up to 20 typical causative agents of opportunistic infections are known, and in modern infectious diseases this list is constantly growing. without symptoms: 60% - cytomegalovirus, 90% - first and second type herpavirus, 30% are toxoplasma c

Style APA, Harvard, Vancouver, ISO itp.

39

Sajjad, Kathem Ashour, Abd Jabbar Al-Ammar Haider, and Hamza Sharif Yasmine. "Interleukin-6 Biomarker as Possible Predicator of Preeclampsia." Biomedicine and Chemical Sciences, no. 4 (September 30, 2022): 306–11. https://doi.org/10.48112/bcs.v1i4.303.

Pełny tekst źródła

Streszczenie:

Preeclampsia (PE) is a serious illness that can harm both mothers and unborn children and may even be fatal. It contributes significantly to maternal fatalities in underdeveloped countries. PE, which affects 2%–3% of women who are pregnant after 20 weeks of pregnancy, is marked by proteinuria and hypertension. PE is a significant condition that plays a significant role in maternal fatalities in underdeveloped countries and is a significant cause of death for both mothers and newborns. Each year, around 60,000 maternal fatalities occur in the world. Serum interleukin-6 (IL-6) was measured

Style APA, Harvard, Vancouver, ISO itp.

40

Hoejberg, Lise, Lars Bastholt, and Henrik Schmidt. "Interleukin-6 and melanoma." Melanoma Research 22, no. 5 (2012): 327–33. http://dx.doi.org/10.1097/cmr.0b013e3283543d72.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

41

Rose-John, Stefan. "Interleukin-6 Family Cytokines." Cold Spring Harbor Perspectives in Biology 10, no. 2 (2017): a028415. http://dx.doi.org/10.1101/cshperspect.a028415.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

42

Tanaka, Toshio, Masashi Narazaki, and Tadamitsu Kishimoto. "Interleukin (IL-6) Immunotherapy." Cold Spring Harbor Perspectives in Biology 10, no. 8 (2017): a028456. http://dx.doi.org/10.1101/cshperspect.a028456.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

43

Suzuki, Kenshi, Akiko Miyashita, Yasuyuki Inoue, et al. "Interleukin-6-Producing Pheochromocytoma." Acta Haematologica 85, no. 4 (1991): 217–19. http://dx.doi.org/10.1159/000204897.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

44

Kerr, Ron, David Stirling, and Christopher A. Ludlam. "Interleukin 6 and Haemostasis." British Journal of Haematology 115, no. 1 (2001): 3–12. http://dx.doi.org/10.1046/j.1365-2141.2001.03061.x.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

45

Nagila, Amar, Khem Raj Paudel, and Bijay Subedi. "Interleukin-6 in Hypothyroidism." Journal of Manmohan Memorial Institute of Health Sciences 9, no. 2 (2024): 27–29. http://dx.doi.org/10.3126/jmmihs.v9i2.71838.

Pełny tekst źródła

Streszczenie:

Background: Hypothyroidism means that the thyroid gland can’t produce enough thyroid hormones. Interleukin 6 (IL-6) a cytokine of innate immunity is a soluble mediator with a pleotropic effect on inflammation. Interleukin 6 test is helpful to study the hypothyroid status and to assess the adverse effects of hypothyroidism, was not studied in a tertiary care center in Pokhara, Nepal. The aim of this study is to determine the levels of interleukin 6 and to correlate with hypothyroidism. Methodology: This was a hospital based cross-sectional study on 100 hypothyroid patients where samples were co

Style APA, Harvard, Vancouver, ISO itp.

46

Sehgal, Pravinkumar B. "Interleukin-6: Molecular Pathophysiology." Journal of Investigative Dermatology 94, no. 6 (1990): s2—s6. http://dx.doi.org/10.1111/1523-1747.ep12874963.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

47

Van Snick, Jacques. "Interleukin-6: An Overview." Annual Review of Immunology 8, no. 1 (1990): 253–78. http://dx.doi.org/10.1146/annurev.iy.08.040190.001345.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

48

Pedersen, Bente Klarlund, Adam Steensberg, and Peter Schjerling. "Exercise and interleukin-6." Current Opinion in Hematology 8, no. 3 (2001): 137–41. http://dx.doi.org/10.1097/00062752-200105000-00002.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

49

Patarca, Roberto, and Mary Ann Fletcher. "Interleukin-6 and Disease." Journal of Chronic Fatigue Syndrome 4, no. 1 (1998): 53–69. http://dx.doi.org/10.1300/j092v04n01_07.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

50

SEHGAL, PRAVIN B., LING WANG, RAVI RAYANADE, HENG PAN, and LOLA MARGULIES. "Interleukin-6-Type Cytokinesa." Annals of the New York Academy of Sciences 762, no. 1 (2006): 1–14. http://dx.doi.org/10.1111/j.1749-6632.1995.tb32309.x.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

Oferujemy zniżki na wszystkie plany premium dla autorów, których prace zostały uwzględnione w tematycznych zestawieniach literatury. Skontaktuj się z nami, aby uzyskać unikalny kod promocyjny!